Bay Colony Advisory Group, Inc D Humacyte, Inc. Transaction History
Bay Colony Advisory Group, Inc D
- $580 Million
- Q2 2024
A detailed history of Bay Colony Advisory Group, Inc D transactions in Humacyte, Inc. stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 14,550 shares of HUMA stock, worth $76,678. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,550
Previous 22,450
35.19%
Holding current value
$76,678
Previous $69,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding HUMA
# of Institutions
130Shares Held
30.8MCall Options Held
323KPut Options Held
582K-
Black Rock Inc. New York, NY7.14MShares$37.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$24.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.87MShares$15.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$9.81 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.6MShares$8.43 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $543M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...